Flyers/Resources to Distribute:
- Sarasota for Vaccination Choice NEW
- Dr. Blaylock & Dr. Mercola Debunk the H1N1 "Pandemic"
- Educate Yourself re: Mass-Vaccination (tri-fold, PDF)
- ** FLORIDA SWINE FLU VACCINE LAWSUIT!
- The Truth about Flu Shots in Pregnancy
- FDA Vaccine Package Inserts: 3 Injectable, 1 Intranasal: PDF's Here
- Swine Flu Arrives in Sarasota: Examining H1N1 'Swine Flu' and the Government's Rush to Vaccinate
- 2009 Florida Statutes: 381.00315 Public health advisories; public health emergencies
- Nuremberg Code: Directives for Human Experimentation
- Adverse Effects of Adjuvants in Vaccines
- Refuse and Resist Mandatory Flu Vaccines
Wednesday, September 16, 2009
Package Insert: Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Limited)
http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM182242.pdf
Sarasota for Vaccination Choice Comment:
Read the fine print, the devil is in the details?
NOTE: This is one of three INJECTABLE H1N1 Vaccines approved by FDA on Sept. 15, 2009. FDA also approved one Intranasal vaccine.
=========
EXCERPT:
<<<
DOSAGE FORMS AND STRENGTHS
Influenza A (H1N1) 2009 Monovalent Vaccine, a sterile suspension for intramuscular injection, is supplied in two presentations:
• Prefilled single dose syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose) (3, 11)
• Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as preservative. (3,11)
>>>
Sarasota for Vaccination Choice Comment:
Read the fine print, the devil is in the details?
NOTE: This is one of three INJECTABLE H1N1 Vaccines approved by FDA on Sept. 15, 2009. FDA also approved one Intranasal vaccine.
=========
EXCERPT:
<<<
DOSAGE FORMS AND STRENGTHS
Influenza A (H1N1) 2009 Monovalent Vaccine, a sterile suspension for intramuscular injection, is supplied in two presentations:
• Prefilled single dose syringe, 0.5-mL. Thimerosal, a mercury derivative used during manufacture, is removed by subsequent purification steps to a trace amount (≤ 1 mcg mercury per 0.5-mL dose) (3, 11)
• Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as preservative. (3,11)
>>>
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment